A cytoreductive conditioning program for bone marrow transplantation in resistant leukemia (SCARI).
D000293:Adolescent; D000328:Adult; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D006087:Graft vs Host Reaction; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D008875:Middle Aged; D012008:Recurrence; D013866:Thioguanine / Q000627:therapeutic use; D014184:Transplantation, Homologous
D003561:Cytarabine; D003520:Cyclophosphamide; D013866:Thioguanine; D003630:Daunorubicin